Castranova V: Overview of current toxicological knowledge of engineered nanoparticles. J Occup Environ Med/Am Coll Occup Environ Med 2011, 53: S14-S17.
Roco MC: Science and technology integration for increased human potential and societal outcomes. Ann N Y Acad Sci 2004, 1013: 1–16. 10.1196/annals.1305.001
Scholars WWIC: Consumer Products: An Inventory of Nanotechnology-based Consumer Products Currenly on the Market. 2012, Accessed 08/23/12 http://www.nanotechproject.org
Nel A, Xia T, Madler L, Li N: Toxic potential of materials at the nanolevel. Science 2006, 311: 622–627. 10.1126/science.1114397
Maynard AD, Kuempel ED: Airborne nanostructured particles and occupational health. J Nanopart Res 2005, 7: 587–614. 10.1007/s11051-005-6770-9
Ajayan PM: Nanotubes from carbon. Chem Rev 1999, 99: 1787–1800. 10.1021/cr970102g
Iijima S: Helical microtubules of graphitic carbon. Nature 1991, 354: 56–58. 10.1038/354056a0
Yakobson BI, Smalley RE: Fullerene nanotubes: C 1,000,000 and Beyond: Some unusual new molecules - long, hollow fibers with tantalizing electronic and mechanical properties - have joined diamonds and graphite in the carbon family. Am Scientist 1997, 85: 324–337.
Donaldson K, Murphy FA, Duffin R, Poland CA: Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010, 7: 5. 10.1186/1743-8977-7-5
Donaldson K, Poland CA: Inhaled nanoparticles and lung cancer - what we can learn from conventional particle toxicology. Swiss Med Wkly 2012, 142: w13547.
Pacurari M, Castranova V, Vallyathan V: Single- and multi-wall carbon nanotubes versus asbestos: are the carbon nanotubes a new health risk to humans? J Toxicol Environ Health A 2010, 73: 378–395. 10.1080/15287390903486527
Porter DW, Hubbs AF, Mercer RR, Wu N, Wolfarth MG, Sriram K, Leonard S, Battelli L, Schwegler-Berry D, Friend S, et al.: Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010, 269: 136–147. 10.1016/j.tox.2009.10.017
Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Friend S, Castranova V, Porter DW: Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol 2011, 8: 21. 10.1186/1743-8977-8-21
Porter DW, Hubbs AF, Chen BT, McKinney W, Mercer RR, Wolfarth MG, Battelli L, Wu N, Sriram K, Leonard S, et al.: Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology 2012. Sep 13. [Epub ahead of print]
Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, Arras M, Fonseca A, Nagy JB, Lison D: Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 2005, 207: 221–231. 10.1016/j.taap.2005.01.008
Snyder-Talkington BN, Qian Y, Castranova V, Guo NL: New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformatics. J Toxicol Environ Health B Crit Rev 2012, 15: 468–492. 10.1080/10937404.2012.736856
He X, Young SH, Schwegler-Berry D, Chisholm WP, Fernback JE, Ma Q: Multiwalled carbon nanotubes induce a fibrogenic response by stimulating reactive oxygen species production, activating NF-kappaB signaling, and promoting fibroblast-to-myofibroblast transformation. Chem Res Toxicol 2011, 24: 2237–2248. 10.1021/tx200351d
Ye SF, Wu YH, Hou ZQ, Zhang QQ: ROS and NF-kappaB are involved in upregulation of IL-8 in A549 cells exposed to multi-walled carbon nanotubes. Biochem Biophys Res Commun 2009, 379: 643–648. 10.1016/j.bbrc.2008.12.137
Pacurari M, Qian Y, Fu W, Schwegler-Berry D, Ding M, Castranova V, Guo NL: Cell permeability, migration, and reactive oxygen species induced by multiwalled carbon nanotubes in human microvascular endothelial cells. J Toxicol Environ Health A 2012, 75: 129–147.
Srivastava RK, Pant AB, Kashyap MP, Kumar V, Lohani M, Jonas L, Rahman Q: Multi-walled carbon nanotubes induce oxidative stress and apoptosis in human lung cancer cell line-A549. Nanotoxicology 2011, 5: 195–207. 10.3109/17435390.2010.503944
Sargent LM, Reynolds SH, Castranova V: Potential pulmonary effects of engineered carbon nanotubes: in vitro genotoxic effects. Nanotoxicology 2010, 4: 396–408. 10.3109/17435390.2010.500444
Warheit DB, Sayes CM, Reed KL: Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures? Environ Sci Technol 2009, 43: 7939–7945. 10.1021/es901453p
Seagrave J, Mauderly JL, Seilkop SK: In vitro relative toxicity screening of combined particulate and semivolatile organic fractions of gasoline and diesel engine emissions. J Toxicol Environ Health A 2003, 66: 1113–1132. 10.1080/15287390390213881
Sayes CM, Reed KL, Warheit DB: Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 2007, 97: 163–180. 10.1093/toxsci/kfm018
Stokstad E: Putting chemicals on a path to better risk assessment. Science 2009, 325: 694–695. 10.1126/science.325_694
Hartung T: Toxicology for the twenty-first century. Nature 2009, 460: 208–212. 10.1038/460208a
Collins FS, Gray GM, Bucher JR: Toxicology, Transforming environmental health protection. Science 2008, 319: 906–907. 10.1126/science.1154619
Brandenberger C, Rothen-Rutishauser B, Muhlfeld C, Schmid O, Ferron GA, Maier KL, Gehr P, Lenz AG: Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. Toxicol Appl Pharmacol 2010, 242: 56–65. 10.1016/j.taap.2009.09.014
Hermanns MI, Kasper J, Dubruel P, Pohl C, Uboldi C, Vermeersch V, Fuchs S, Unger RE, Kirkpatrick CJ: An impaired alveolar-capillary barrier in vitro: effect of proinflammatory cytokines and consequences on nanocarrier interaction. J R Soc, Interface /R Soc 2010,7(Suppl 1):S41-S54.
Hermanns MI, Unger RE, Kehe K, Peters K, Kirkpatrick CJ: Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro. Lab Invest; J Tech Meth Pathol 2004, 84: 736–752. 10.1038/labinvest.3700081
Kasper J, Hermanns MI, Bantz C, Maskos M, Stauber R, Pohl C, Unger RE, Kirkpatrick JC: Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: comparison with conventional monocultures. Part Fibre Toxicol 2011, 8: 6. 10.1186/1743-8977-8-6
Klein SG, Hennen J, Serchi T, Blomeke B, Gutleb AC: Potential of coculture in vitro models to study inflammatory and sensitizing effects of particles on the lung. Toxicol In Vitro: Int J Published Assoc BIBRA 2011, 25: 1516–1534. 10.1016/j.tiv.2011.09.006
Muller L, Riediker M, Wick P, Mohr M, Gehr P, Rothen-Rutishauser B: Oxidative stress and inflammation response after nanoparticle exposure: differences between human lung cell monocultures and an advanced three-dimensional model of the human epithelial airways. J R Soc, Interface /R Soc 2010,7(Suppl 1):S27-S40.
Rothen-Rutishauser B, Blank F, Muhlfeld C, Gehr P: In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Expert Opin Drug Metab Toxicol 2008, 4: 1075–1089. 10.1517/17425255.4.8.1075
Wottrich R, Diabate S, Krug HF: Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. Int J Hyg Environ Health 2004, 207: 353–361. 10.1078/1438-4639-00300
Napierska D, Quarck R, Thomassen LC, Lison D, Martens JA, Delcroix M, Nemery B, Hoet PH: Amorphous silica nanoparticles promote monocyte adhesion to human endothelial cells: size-dependent effect. Small 2013, 9: 430–438. 10.1002/smll.201201033
Dudek SM, Garcia JG: Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001, 91: 1487–1500.
Shi W, Xu J, Warburton D: Development, repair and fibrosis: what is common and why it matters. Respirology 2009, 14: 656–665. 10.1111/j.1440-1843.2009.01565.x
Strieter RM: What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. Proc Am Thorac Soc 2008, 5: 305–310. 10.1513/pats.200710-160DR
Strieter RM, Mehrad B: New mechanisms of pulmonary fibrosis. Chest 2009, 136: 1364–1370. 10.1378/chest.09-0510
Snyder-Talkington BN, Pacurari M, Dong C, Leonard S, Schwegler-Berry D, Castranova V, Qian Y, Guo NL: Systematic analysis of multi-walled carbon nanotube-induced cellular signaling and gene expression in human small airway epithelial cells. Toxicol Sci 2013, 133: 79–89. 10.1093/toxsci/kft019
Folkman J: Angiogenesis: an organizing principle for drug discovery? Nature reviews Drug discovery 2007, 6: 273–286. 10.1038/nrd2115
Hancock JT, Desikan R, Neill SJ: Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans 2001, 29: 345–350. 10.1042/BST0290345
Roberts RA, Smith RA, Safe S, Szabo C, Tjalkens RB, Robertson FM: Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. Toxicology 2010, 276: 85–94. 10.1016/j.tox.2010.07.009
Tabima DM, Frizzell S, Gladwin MT: Reactive oxygen and nitrogen species in pulmonary hypertension. Free Radic Biol Med 2012, 52: 1970–1986. 10.1016/j.freeradbiomed.2012.02.041
Stapleton PA, Minarchick VC, Cumpston AM, McKinney W, Chen BT, Sager TM, Frazer DG, Mercer RR, Scabilloni J, Andrew ME, et al.: Impairment of coronary arteriolar endothelium-dependent dilation after multi-walled carbon nanotube inhalation: a time-course study. Int J Mol Sci 2012, 13: 13781–13803. 10.3390/ijms131113781
Hirase T, Node K: Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol 2012, 302: H499-H505. 10.1152/ajpheart.00325.2011
Csortos C, Kolosova I, Verin AD: Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family. Am J Physiol Lung Cell Mol Physiol 2007, 293: L843-L854. 10.1152/ajplung.00120.2007
Vandenbroucke E, Mehta D, Minshall R, Malik AB: Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008, 1123: 134–145. 10.1196/annals.1420.016
Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, Ruco LP, Dejana E: A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 1992, 118: 1511–1522. 10.1083/jcb.118.6.1511
Harris ES, Nelson WJ: VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Curr Opin Cell Biol 2010, 22: 651–658. 10.1016/j.ceb.2010.07.006
Tuder RM, Yun JH: Vascular endothelial growth factor of the lung: friend or foe. Curr Opin Pharmacol 2008, 8: 255–260. 10.1016/j.coph.2008.03.003
Weis SM, Cheresh DA: Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005, 437: 497–504. 10.1038/nature03987
Gavard J, Gutkind JS: VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006, 8: 1223–1234. 10.1038/ncb1486
Muller WA: Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol 2011, 6: 323–344. 10.1146/annurev-pathol-011110-130224
Lawson C, Wolf S: ICAM-1 signaling in endothelial cells. Pharmacological reports: PR 2009, 61: 22–32.
Chang JF, Hsu SP, Pai MF, Yang JY, Chen HY, Wu HY, Peng YS: High soluble vascular cell adhesion molecule-1 concentrations predict long-term mortality in hemodialysis patients. Int Urol Nephrol 2013. Apr 6. [Epub ahead of print]
Gao H, Ward PA: STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses. Expert Opin Ther Targets 2007, 11: 869–880. 10.1517/14728222.11.7.869
Rahman A, Fazal F: Blocking NF-kappaB: an inflammatory issue. Proc Am Thorac Soc 2011, 8: 497–503. 10.1513/pats.201101-009MW
Moodley YP, Misso NL, Scaffidi AK, Fogel-Petrovic M, McAnulty RJ, Laurent GJ, Thompson PJ, Knight DA: Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol 2003, 29: 490–498. 10.1165/rcmb.2002-0262OC
Hoefen RJ, Berk BC: The role of MAP kinases in endothelial activation. Vascul Pharmacol 2002, 38: 271–273. 10.1016/S1537-1891(02)00251-3
Pietersma A, Tilly BC, Gaestel N, DeJong N, Lee JC, Koster JF, Sluiter W: P38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun 1997, 230: 44–48. 10.1006/bbrc.1996.5886
Wang Q, Doerschuk CM: The p38 mitogen-activated protein kinase mediates cytoskeletal remodeling in pulmonary microvascular endothelial cells upon intracellular adhesion molecule-1 ligation. J Immunol 2001, 166: 6877–6884.
Porter D, Sriram K, Wolfarth M, Jefferson A, Schwegler-Berry D, Andrew M, Castranova V: A biocompatible medium for nanoparticle dispersion. Nanotoxicology 2008, 2: 144–154. 10.1080/17435390802318349
Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Schwegler-Berry D, Castranova V, Porter DW: Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol 2010, 7: 28. 10.1186/1743-8977-7-28
Han JH, Lee EJ, Lee JH, So KP, Lee YH, Bae GN, Lee SB, Ji JH, Cho MH, Yu IJ: Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facility. Inhal Toxicol 2008, 20: 741–749. 10.1080/08958370801942238
Piao CQ, Liu L, Zhao YL, Balajee AS, Suzuki M, Hei TK: Immortalization of human small airway epithelial cells by ectopic expression of telomerase. Carcinogenesis 2005, 26: 725–731. 10.1093/carcin/bgi016
Shao R, Guo X: Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochem Biophys Res Commun 2004, 321: 788–794. 10.1016/j.bbrc.2004.07.033
Qian Y, Liu KJ, Chen Y, Flynn DC, Castranova V, Shi X: Cdc42 regulates arsenic-induced NADPH oxidase activation and cell migration through actin filament reorganization. J Biol Chem 2005, 280: 3875–3884.